World Journal of Endocrine Surgery

Register      Login

VOLUME 2 , ISSUE 3 ( September-December, 2010 ) > List of Articles

REVIEW ARTICLE

Anesthetic Management of Pheochromocytoma

Derek T Woodrum, Sachin Kheterpal

Citation Information : Woodrum DT, Kheterpal S. Anesthetic Management of Pheochromocytoma. World J Endoc Surg 2010; 2 (3):111-117.

DOI: 10.5005/jp-journals-10002-1034

Published Online: 01-12-2010

Copyright Statement:  Copyright © 2010; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

The anesthetic management of pheochromocytoma is complicated and challenging. However, preoperative pharmacologic preparation has greatly improved perioperative outcome, and modern anesthetic drugs combined with advanced monitoring contribute to intraoperative stability. There is great regional and international variation in which intraoperative anesthetic technique is employed and there are little data to suggest one approach over another. Nevertheless, most management principles are universal. Progress lies in improved data collection that is increasingly available with electronic anesthesia information systems.


PDF Share
  1. Anesthesia for patients with pheochromocytoma. Anesthesiology Clin North Am 1987;5:269-75.
  2. The north american neuroendocrine tumor society consensus guideline for the diagnosis and management of neuroendocrine tumors: Pheochromocytoma, paraganglioma, and medullary thyroid cancer. Pancreas 2010;39(6):775-83.
  3. Pathology and Genetics of Tumours of Endocrine Organs. In: World Health Organization Classification of Tumors. Lyon, France: IARC Press; 2004.
  4. Increased urinary excretion of 3-methoxytyramine in patients with head and neck paragangliomas. The Journal of clinical endocrinology and metabolism 2010;95(1):209-14.
  5. Pheochromocytoma manifesting with shock presents a clinical paradox: A case report. Canadian Medical Association Journal; CMAJ 1997;157(7):923-25.
  6. Pheochromocytoma masquerading as a cardiomyopathy. The American journal of cardiology 1972;29(4):568-71.
  7. Pheochromocytoma presenting as possible cardiomyopathy. Giornale italiano di cardiologia 1982;12(11):826-30.
  8. Pheochromocytoma presenting after cardiac transplantation for dilated cardiomyopathy. The Journal of heart and lung transplantation 2001;20(7):773-75.
  9. Orthostatic hypotension as an unusual clinical manifestation of pheochromocytoma: A case report. Journal of cardiovascular medicine 2008;9(8):839-41.
  10. Case records of the Massachusetts General Hospital. Case 14-2010. A 54-year-old woman with dizziness and falls. The New England journal of medicine 2010;362(19):1815-23.
  11. Uncommon cause of cardiac arrest in the emergency department. Emergency medicine Australasia 2007;19(2):169-72.
  12. A systematic review of the literature examining the diagnostic efficacy of measurement of fractionated plasma free metanephrines in the biochemical diagnosis of pheochromocytoma. BMC endocrine disorders 2004;4(1):2.
  13. Pheochromocytoma: Recommendations for clinical practice from the First International Symposium. October 2005. Nature clinical practice endocrinology and metabolism 2007;3(2):92-102.
  14. Biochemical diagnosis of pheochromocytoma: Which test is best? JAMA (Chicago, Ill) 2002;287(11):1427-34.
  15. A comparison of biochemical tests for pheochromocytoma: Measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. The Journal of clinical endocrinology and metabolism 2003;88(2):553-58.
  16. QRS amplitudes, QTc intervals and ECG abnormalities in pheochromocytoma patients before, during and after treatment. Acta medica Scandinavica 1988;224(3):231-35.
  17. Clinical experience over 48 years with pheochromocytoma. Annals of surgery 1999;229(6):755-64.
  18. Perioperative management of 63 patients with pheochromocytoma. Cleveland Clinic journal of medicine 1990;57(7):613-17.
  19. Preoperative management of the pheochromocytoma patient. The Journal of clinical endocrinology and metabolism 2007;92(11): 4069-79.
  20. Safe and cost-effective preoperative preparation of patients with pheochromocytoma. Anesthesia and analgesia 2000;91(2):302-04.
  21. Perioperative management of pheochromocytoma. Journal of cardiothoracic and vascular anesthesia 2002;16(3):359-69.
  22. Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma. World journal of surgery 2002;26(8):1037-42.
  23. The effect of calcium channel blockers on outcome following the surgical treatment of phaeochromocytomas and paragangliomas. Anaesthesia 2005;60(5):439-44.
  24. The preoperative management of phaeochromocytoma. Anaesthesia and intensive care 1998;26(2):196-200.
  25. Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma. Urology 2010;76(2):508.e6-11.
  26. Effects of perioperative alpha1 block on haemodynamic control during laparoscopic surgery for phaeochromocytoma. British Journal of Anaesthesia 2004;92(4): 512-17.
  27. Metyrosine and pheochromocytoma. Archives of internal medicine 1997;157(8):901-06.
  28. Pheochromocytoma: Specialist cases that all must be prepared to treat? Journal of cardiothoracic and vascular anesthesia 2002;16(3):267-69.
  29. Surgical management of pheochromocytoma with the use of metyrosine. Annals of surgery 1990;212(5):621-28.
  30. Short-term effects of octreotide on blood pressure and plasma catecholamines and neuropeptide Y levels in patients with phaeochromocytoma: a placebo-controlled trial. Clinical endocrinology 1995;42(3):289-94.
  31. Circulating dihydroxyphenylglycol and norepinephrine concentrations during sympathetic nervous system activation in patients with pheochromocytoma. The Journal of clinical endocrinology and metabolism 1994;79(6):1609-14.
  32. Phaeochromocytoma—Recent progress in its management. British Journal of Anaesthesia 2000;85(1):44-57.
  33. Changes in arterial pressure during mechanical ventilation. Anesthesiology 2005;103(2):419-28.
  34. Measurement of systolic pressure variation during graded volume loss using simple tools on Datex Ohmeda S/5 monitor. Journal of neurosurgical anesthesiology 2009;21(2):161-64.
  35. A comparison of systolic blood pressure variations and echocardiographic estimates of end-diastolic left ventricular size in patients after aortic surgery. Anesthesia and analgesia 1994;78(1):46-53.
  36. Systolic blood pressure variation is a sensitive indicator of hypovolemia in ventilated dogs subjected to graded hemorrhage. Anesthesiology 1987;67(4):498-502.
  37. Measurement of systolic pressure variation on a Datex AS/3 monitor. Anesthesia and analgesia 2005;100(6):1864.
  38. Systolic pressure variation (Deltadown) can guide fluid therapy during pheochromocytoma surgery. Canadian journal of anesthesia 2003;50(10):998-1003.
  39. Anaesthetic management of patients with phaeochromocytoma. A review of 102 cases. British Journal of Anaesthesia 1977;49(10):991-98.
  40. Anaesthetic management of patients with phaeochromocytoma. British Journal of Anaesthesia 1984;56(7):781-89.
  41. Laparoscopic approach to pheochromocytoma: Is a lower intraabdominal pressure helpful? Anesthesia and analgesia 2006;102(2):637-41.
  42. Phaeochromocytoma. Diagnosis, preoperative preparation and anaesthetic management. British Journal of Anaesthesia 1986;58(12): 1453-68.
  43. Remifentanil preventing hemodynamic changes during laparoscopic adrenalectomy for pheochromocytoma. Middle East journal of anaesthesiology 2006;18(5):947-54.
  44. Anaesthesia for phaeochromocytoma in pregnancy. Canadian journal of anesthesia 1997;44(6):654-57.
  45. Use of desflurane during resection of phaeochromocytoma. British Journal of Anaesthesia 1994;72(6):707-09.
  46. Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers. A comparison with isoflurane. Anesthesiology 1993;79(3):444-53.
  47. Identification of receptor mechanism mediating epinephrine-induced arrhythmias during halothane anesthesia in the dog. Anesthesiology 1983;59(4):322-26.
  48. Histamine and glucagon tests in diagnosis of pheochromocytoma. JAMA (Chicago, Ill) 1968;205(13):895-99.
  49. Remifentanil for modulation of hemodynamics in a patient undergoing laparoscopic resection of pheochromocytoma. Middle East journal of anaesthesiology 2004;17(4): 585-92.
  50. Anesthesia management with short acting agents for bilateral pheochromocytoma removal in a 12-year-old boy. Paediatric anaesthesia 2006;16(11):1184-88.
  51. The use of remifentanil in the anaesthetic management of patients undergoing adrenalectomy: A report of three cases. Anaesthesia 2003;58(4):358-62.
  52. Mechanism of the effect of droperidol to induce catecholamine efflux from the adrenal medulla. Anesthesiology 1985;62(1):17-22.
  53. A dopaminergic receptor in adrenal medulla as a possible site of action for the droperidolevoked hypertensive response. Anesthesiology 1986;65(5):474-79.
  54. Droperidol and pheochromocytoma. Anesthesia and analgesia 1981;60(10):770-71.
  55. Innovar-induced hypertensive crises in patients with pheochromocytoma. Anesthesiology 1979;50(4):366-69.
  56. Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors. Endocrine-related cancer 2009;16(1):281-90.
  57. Increased arterial pressure is not predictive of haemodynamic instability in patients undergoing adrenalectomy for phaeochromocytoma. Acta anaesthesiologica scandinavica 2009;53(4):522-27.
  58. Perioperative management of phaeochromocytoma. Acta Anaesthesiologica Belgica 2009;60(1):55-66.
  59. Pheochromocytoma crisis: The use of magnesium sulfate. Anesthesia and analgesia 2004;99(3):680-86.
  60. Phaeochromocytoma: An unusual cause of hypertension in pregnancy. Anaesthesia 2001;56(1): 43-46.
  61. Magnesium sulphate for phaeochromocytoma crisis. Emergency medicine Australasia 2007;19(5):482.
  62. Use of magnesium sulphate in the anaesthetic management of phaeochromocytoma: A review of 17 anaesthetics. British Journal of Anaesthesia 1989;62(6):616-23.
  63. An effective use of magnesium sulfate for intraoperative management of laparoscopic adrenalectomy for pheochromocytoma in a pediatric patient. Anesthesia and analgesia 2002;95(5):1243-44.
  64. Dexmedetomidine infusion during surgery in patients with a pheochromocytoma. Acta anaesthesiologica scandinavica 2010;54(3):393-94.
  65. Dexmedetomidine and magnesium sulfate in the perioperative management of a child undergoing laparoscopic resection of bilateral pheochromocytomas. Journal of clinical anesthesia 2010;22(2):126-29.
  66. Dexmedetomidine for resection of a large phaeochromocytoma with invasion into the inferior vena cava. British Journal of Anaesthesia 2004;93(6):873.
  67. Prospective randomized comparison of laparoscopic versus open adrenalectomy for sporadic pheochromocytoma. Surgical endoscopy 2008;22(6):1435-39.
  68. Induction of anesthesia triggers hypertensive crisis in a patient with undiagnosed pheochromocytoma: Could rocuronium be to blame? Journal of cardiothoracic and vascular anesthesia 2007;21(6): 858-62.
  69. Vasopressin for hemodynamic rescue in catecholamine-resistant vasoplegic shock after resection of massive pheochromocytoma. Anesthesiology 2004;101(4): 1022-24.
  70. The use of vasopressin to treat catecholamine-resistant hypotension after phaeochromocytoma removal. Anaesthesia and intensive care 2002;30(4):477-80.
  71. Vasopressin to treat hypotension after pheochromocytoma resection in an eleven-year-old boy. Journal of cardiothoracic and vascular anesthesia 2006;20(3):394-96.
  72. Use of vasopressin bolus and infusion to treat catecholamineresistant hypotension during pheochromocytoma resection. Anesthesiology 2007;106(4):883-84.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.